410 related articles for article (PubMed ID: 16510574)
1. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
Shin SR; Sánchez-Velar N; Sherr DH; Sonenshein GE
Cancer Res; 2006 Mar; 66(5):2570-5. PubMed ID: 16510574
[TBL] [Abstract][Full Text] [Related]
2. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
[TBL] [Abstract][Full Text] [Related]
3. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.
Eddy SF; Guo S; Demicco EG; Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2005 Dec; 65(24):11375-83. PubMed ID: 16357145
[TBL] [Abstract][Full Text] [Related]
4. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
5. Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells.
Kim DW; Sovak MA; Zanieski G; Nonet G; Romieu-Mourez R; Lau AW; Hafer LJ; Yaswen P; Stampfer M; Rogers AE; Russo J; Sonenshein GE
Carcinogenesis; 2000 May; 21(5):871-9. PubMed ID: 10783306
[TBL] [Abstract][Full Text] [Related]
6. Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype.
Belguise K; Guo S; Yang S; Rogers AE; Seldin DC; Sherr DH; Sonenshein GE
Cancer Res; 2007 Dec; 67(24):11742-50. PubMed ID: 18089804
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
Huber MA; Azoitei N; Baumann B; Grünert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
[TBL] [Abstract][Full Text] [Related]
8. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.
Romieu-Mourez R; Kim DW; Shin SM; Demicco EG; Landesman-Bollag E; Seldin DC; Cardiff RD; Sonenshein GE
Mol Cell Biol; 2003 Aug; 23(16):5738-54. PubMed ID: 12897145
[TBL] [Abstract][Full Text] [Related]
9. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE
Cancer Res; 2002 Nov; 62(22):6770-8. PubMed ID: 12438279
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
[TBL] [Abstract][Full Text] [Related]
12. The canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansion.
Liu M; Sakamaki T; Casimiro MC; Willmarth NE; Quong AA; Ju X; Ojeifo J; Jiao X; Yeow WS; Katiyar S; Shirley LA; Joyce D; Lisanti MP; Albanese C; Pestell RG
Cancer Res; 2010 Dec; 70(24):10464-73. PubMed ID: 21159656
[TBL] [Abstract][Full Text] [Related]
13. The role of NF-kappaB as a survival factor in environmental chemical-induced pre-B cell apoptosis.
Mann KK; Doerre S; Schlezinger JJ; Sherr DH; Quadri S
Mol Pharmacol; 2001 Feb; 59(2):302-9. PubMed ID: 11160867
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.
Chua HL; Bhat-Nakshatri P; Clare SE; Morimiya A; Badve S; Nakshatri H
Oncogene; 2007 Feb; 26(5):711-24. PubMed ID: 16862183
[TBL] [Abstract][Full Text] [Related]
15. PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.
Belguise K; Sonenshein GE
J Clin Invest; 2007 Dec; 117(12):4009-21. PubMed ID: 18037997
[TBL] [Abstract][Full Text] [Related]
16. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
Kim DW; Gazourian L; Quadri SA; Romieu-Mourez R; Sherr DH; Sonenshein GE
Oncogene; 2000 Nov; 19(48):5498-506. PubMed ID: 11114727
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2.
Wang X; Belguise K; Kersual N; Kirsch KH; Mineva ND; Galtier F; Chalbos D; Sonenshein GE
Nat Cell Biol; 2007 Apr; 9(4):470-8. PubMed ID: 17369819
[TBL] [Abstract][Full Text] [Related]
18. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
Bendinelli P; Matteucci E; Maroni P; Desiderio MA
Mol Cancer Res; 2009 Aug; 7(8):1328-41. PubMed ID: 19671685
[TBL] [Abstract][Full Text] [Related]
20. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
